PMS61 Rapid Reductions in Fatigue and Sleep Problems and Correlation with Improvements in Patient-Reported Outcomes in Patients with Active RA Treated with Certolizumab Pegol in the realistic 12-Week Phase IIIB Randomised Controlled Study
Abstract
Authors
J. Pope R. Fleischmann M. Dougados C.O. Bingham E. Massarotti J. Wollenhaupt B. Duncan G. Coteur M.E. Weinblatt